Horse Melanoma: Advanced Management and Welfare

Melanomas are extremely common in grey horses. Understanding the progression of these tumors and management options supports long-term welfare of affected horses.

Key Facts

Over 80% of grey horses develop melanomas by age 15
Melanomas most commonly appear under the tail, around the perineum, and on the parotid glands
Most equine melanomas are initially benign but a proportion undergo malignant transformation over time
Large melanoma clusters under the tail can interfere with defecation and urination
Cimetidine, immunostimulants, and cisplatin injections are used with variable evidence of efficacy
Surgical removal of single, accessible lesions can be curative in early cases

Welfare Considerations

Advanced equine melanomas cause welfare impacts through physical obstruction and malignant transformation. Perineal melanomas can obstruct defecation, causing significant discomfort and systemic effects of fecal retention. Large parotid melanomas can cause dysphagia. The slow progression of most melanomas means welfare impacts accumulate over years, requiring regular reassessment of the horse's quality of life and appropriate intervention thresholds.

What You Can Do

Inspect grey horses regularly for melanoma development, particularly in the perineal area
Seek early veterinary assessment of new or growing melanomas to document and plan management
Consider early surgical removal of accessible, single lesions before they enlarge
Monitor defecation and urination in horses with perineal melanomas
Discuss pharmacological management options with your vet for horses with progressive disease
Have honest quality of life discussions with your vet as melanoma burden increases with age